Sebastian Stasik

17PUBLICATIONS
80CO-AUTHORS
Medical mycologyPredictive and prognostic markersHaematological tumoursMedical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 08, 2025
Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.

Jan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries

|Mar 05, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.

Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig

|Jan 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AML.

Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer

|Oct 13, 2023
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.

Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig

Pageof 3